Skip to main content

Rural Health
Resources by Topic: Illicit drug use

Federal SUD/OUD Resources and Funding Opportunities in Support of Rural Communities
Highlights the slides of several breakout sessions from the 2020 RCORP conference discussing funding and resources pertaining to opioid use disorder in rural communities. Features presentations from representatives of the Department of Labor, Bureau of Justice Assistance, Appalachian Regional Commission, Bureau of Health Workforce, and the Federal Transit Administration.
Additional links: Agenda, Session 2 Presentations
Date: 03/2020
Type: Document
Sponsoring organization: Rural Communities Opioid Response Program - Technical Assistance
view details
Drug and Opioid-Involved Overdose Deaths — United States, 2017–2018
Examines drug overdose deaths involving all opioids, prescription opioids, heroin, and synthetic opioids other than methadone. Includes data by county urbanization level for metropolitan and nonmetro counties.
Author(s): Nana Wilson, Mbabazi Kariisa, Puja Seth, et al.
Citation: MMWR (Morbidity and Mortality Weekly Report), 69(11), 290-297
Date: 03/2020
Type: Document
Sponsoring organization: Centers for Disease Control and Prevention
view details
Prevalence of Tobacco Use Among Rural-Dwelling Individuals Who Inject Drugs
Research letter describing a study assessing the prevalence of smoking through a multi-site survey of people who inject drugs, conducted during 2018-2019 in rural Wisconsin. Features statistics on participant characteristics.
Author(s): Wajiha Z. Akhtar, Marlon P. Mundt, Ruth Koepke, et al.
Citation: JAMA Network Open, 3(3)
Date: 03/2020
Type: Document
view details
Medications for Opioid Use Disorder: The Treatment Improvement Protocol (TIP) 63
Details guidelines for implementing medication assisted treatment (MAT) of opioid use disorder (OUD) for healthcare professionals, policymakers, patients, and families. Discusses the different medications available to treat OUD, how and when to administer them, as well as what to watch for when using MAT for OUD.
Date: 02/2020
Type: Document
Sponsoring organization: Substance Abuse and Mental Health Services Administration
view details
Rural-Urban Differences in Hospitalizations for Opioid Use-Associated Infective Endocarditis in the United States, 2003-2016
Using 2003-2016 National Inpatient Sample data compares trends between rural and urban populations in hospitalization for opioid use-associated infective endocarditis, a serious heart infection that can result from injection drug use.
Author(s): E Katherine Nenninger, Jenny L Carwile, Katherine A Ahrens, Brett Armstrong, Kinna Thakarar
Citation: Open Forum Infectious Diseases, 7(2)
Date: 02/2020
Type: Document
view details
Availability of Naloxone at Rural Georgia Pharmacies, 2019
Research letter describing a study of 374 rural Georgia pharmacies. Examines pharmacists' awareness of the Georgia law allowing purchase of naloxone without a prescription, and availability and cost of the medicine.
Author(s): Jennifer L. Nguyen, Lauren R. Gilbert, Lauren Beasley, et al.
Citation: JAMA Network Open, 3(2)
Date: 02/2020
Type: Document
view details
National Drug Control Strategy
Report highlights the White House's overall strategy for controlling drug use across the country. Addresses prevention, education, and prescribing practices, as well as increasing access to treatment in rural, tribal, and underserved areas.
Date: 02/2020
Type: Document
Sponsoring organization: The White House Office of National Drug Control Policy
view details
Socioeconomic Risk Factors for Fatal Opioid Overdoses in the United States: Findings from the Mortality Disparities in American Communities Study (MDAC)
Highlights a study that correlates demographic and socioeconomic status with opioid overdose fatalities. Draws data from the Mortality Disparities in American Community Study (MSAC) and compares results by rural/nonrural residence, race, employment, and educational attainment, among other measures.
Author(s): Sean F. Altekruse, Candace M. Cosgrove, William C. Altekruse, Richard A. Jenkins, Carlos Blanco
Citation: PLoS One, 15(1)
Date: 01/2020
Type: Document
view details
Geographic Disparities Affect Access to Buprenorphine Services for Opioid Use Disorder
Results of a national study to determine the patient capacity of healthcare providers who received waivers to prescribe buprenorphine and the extent to which they were located in rural or urban areas with high rates of opioid abuse. Features county-level maps showing rates of patient capacity and counties with high need for treatment services, as of 2018.
Author(s): Christi A. Grimm
Date: 01/2020
Type: Document
Sponsoring organization: Office of Inspector General (HHS)
view details
New Mexico Substance Use Disorder Treatment Gap Analysis
An overview of substance use disorder (SUD) treatment services available in the state by county. Includes alcohol-related death rates and drug overdose death rates. Presents estimates of the people living with SUD who are in treatment or are in need of treatment. Offers recommendations for additional services needed to maximize and address the current gaps in services.
Date: 01/2020
Type: Document
Sponsoring organization: New Mexico Department of Health
view details